{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:09:28Z","timestamp":1764047368008,"version":"3.41.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-025-10259-1","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:27:07Z","timestamp":1742358427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prostate cancer-specific proinflammatory cytokines and chemokines impact on cancer stem cell development, lineage plasticity and heterogeneity in an Ancestral\/racially diverse population: review"],"prefix":"10.1007","volume":"44","author":[{"given":"Powell","family":"Isaac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hudson","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teslow","family":"Emily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heath","family":"Elisabeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raz","family":"Avraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bollig-Fischer","family":"Aliccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"10259_CR1","unstructured":"Seer.cancer.gov\/seerstat prostate cancer incidence and mortality rates, racial differences, 1976\u20132022"},{"key":"10259_CR2","doi-asserted-by":"publisher","unstructured":"Rayford W, Beksac AT, Alger J, Alshalalfa M, Ahmed M, Khan I, Falagario UG, Liu Y, Davicioni E, Spratt DE, Schaeffer EM, Feng FY, Mahal B, Nguyen PL, Den RB, Greenberger MD, Bradley R, Watson JM, Beamer M, Stamatakis L, Carmen DJ, Awasthi S, Hwang J, Weil R, Merisaari H, Mohamed N, Deane LA, Chakravarty D, Yadav KK, Yamoah K, Nair SS, Tewari AK. (2021) Commun Biol. 4(1):670. https:\/\/doi.org\/10.1038\/s42003-021-02140-y","DOI":"10.1038\/s42003-021-02140-y"},{"key":"10259_CR3","doi-asserted-by":"publisher","unstructured":"Tsion Zewdu Minas\u00a0#\u00a01,\u00a0Juli\u00e1n Candia\u00a0#\u00a01\u00a02,\u00a0Tiffany H Dorsey\u00a01,\u00a0Francine Baker\u00a01,\u00a0Wei Tang\u00a01,\u00a0Maeve Kiely\u00a01,\u00a0Cheryl J Smith\u00a01,\u00a0Amy L Zhang\u00a01,\u00a0Symone V Jordan\u00a01,\u00a0Obadi M Obadi\u00a01,\u00a0Anuoluwapo Ajao\u00a01,\u00a0Yao Tettey\u00a03,\u00a0Richard B Biritwum\u00a03,\u00a0Andrew A Adjei\u00a03,\u00a0James E Mensah\u00a03,\u00a0Robert N Hoover\u00a04,\u00a0Frank J Jenkins\u00a05,\u00a0Rick Kittles\u00a06,\u00a0Ann W Hsing\u00a07\u00a08,\u00a0Xin W Wang\u00a01\u00a09,\u00a0Christopher A Loffredo\u00a010,\u00a0Clayton Yates\u00a011,\u00a0Michael B Cook\u00a04,\u00a0Stefan Ambs\u00a012-Nat Commun 2022 Apr 1;13(1):1759 https:\/\/doi.org\/10.1038\/s41467-022-29235-2.","DOI":"10.1038\/s41467-022-29235-2"},{"issue":"3","key":"10259_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41391-020-0213-7","volume":"23","author":"O Sartor","year":"2020","unstructured":"Sartor, O. (2020). Andrew J Armstrong, Chiledum Ahaghotu, David G McLeod, Matthew R Cooperberg, David F Penson, Philip W Kantoff, Nicholas J Vogelzang, Arif Hussain, Christopher M Pieczonka, Neal D Shore, David Quinn, Eric J Small, Elisabeth I Heath, Ronald F Tutrone, Paul F Schellhammer, Matthew Harmon, Nancy N Chang, Nadeem A Sheikh, Bruce Brown, Stephen J Freedland, Celestia S Higano. Prostate Cancer and Prostatic Diseases, 23(3), 517\u2013526. https:\/\/doi.org\/10.1038\/s41391-020-0213-7","journal-title":"Prostate Cancer and Prostatic Diseases"},{"issue":"2","key":"10259_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.canlet.2013.07.031","volume":"345","author":"S Shigdar","year":"2014","unstructured":"Shigdar, S., Li, Y., Bhattacharya, S., O\u2019Connor, M., Pu, C., Lin, J., Wang, T., Xiang, D., Kong, L., Wei, M. Q., Zhu, Y., Zhou, S., & Duan, W. (2014). Inflammation and cancer stem cells. Cancer Letters, 345(2), 271\u2013278.","journal-title":"Cancer Letters"},{"issue":"19","key":"10259_CR6","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-10-2743","volume":"17","author":"H Korkaya","year":"2011","unstructured":"Korkaya, H., Liu, S., & Wicha, M. S. (2011). Regulation of cancer stem cells by cytokine networks: Attacking cancer\u2019s inflammatory roots. Clinical Cancer Research, 17(19), 6125\u20136129. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2743","journal-title":"Clinical Cancer Research"},{"issue":"5","key":"10259_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/1055-9965.EPI-12-1238","volume":"22","author":"IJ Powell","year":"2013","unstructured":"Powell, I. J., Dyson, G., Land, S., Ruterbusch, J., Bock, C. H., Lenk, S., Herawi, M., Everson, R., Giroux, C. N., Schwartz, A. G., & Bollig-Fischer, A. (2013). Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer epidemiology, biomarkers & prevention\u202f: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 22(5), 891\u2013897. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-1238","journal-title":"Cancer epidemiology, biomarkers & prevention : A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"1","key":"10259_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urolonc.2020.08.019","volume":"39","author":"IJ Powell","year":"2021","unstructured":"Powell, I. J., Chinni, S. R., Reddy, S. S., Zaslavsky, A., & Gavande, N. (2021). Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic\/biologic mechanism of racial disparity: Update. Urologic Oncology, 39(1), 34\u201340. https:\/\/doi.org\/10.1016\/j.urolonc.2020.08.019","journal-title":"Urologic Oncology"},{"key":"10259_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajur.2015.04.011","volume":"2","author":"Z Cao","year":"2015","unstructured":"Cao, Z., & Kyprianou, N. (2015). Mechanisms navigating the TGF-beta pathway in prostate cancer. Asian Journal of Urology, 2, 11\u201318.","journal-title":"Asian Journal of Urology"},{"issue":"Pt 3","key":"10259_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.semcancer.2022.02.017","volume":"86","author":"M Mughees","year":"2022","unstructured":"Mughees, M., Kaushal, J. B., Sharma, G., Wajid, S., Batra, S. K., & Siddiqui, J. A. (2022). Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis. Seminars in Cancer Biology, 86(Pt 3), 497\u2013512. https:\/\/doi.org\/10.1016\/j.semcancer.2022.02.017","journal-title":"Seminars in Cancer Biology"},{"key":"10259_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/jcb.22278","volume":"108","author":"CY Tsai","year":"2009","unstructured":"Tsai, C. Y., Lee, T. S., Kou, Y. R., & Wu, Y. L. (2009). Glucosamine inhibits IL-1beta-mediated IL-8 production in prostate cancer cells by MAPK attenuation. Journal of Cellular Biochemistry, 108, 489\u2013498.","journal-title":"Journal of Cellular Biochemistry"},{"key":"10259_CR12","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","volume":"14","author":"DJ Waugh","year":"2008","unstructured":"Waugh, D. J., & Wilson, C. (2008). The interleukin-8 pathway in cancer. Clinical Cancer Research, 14, 6735\u20136741.","journal-title":"Clinical Cancer Research"},{"key":"10259_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2353\/ajpath.2009.080727","volume":"175","author":"L Zhang","year":"2009","unstructured":"Zhang, L., Altuwaijri, S., Deng, F., Chen, L., Lal, P., Bhanot, U. K., et al. (2009). NF-kappaB regulates androgen receptor expression and prostate cancer growth. American Journal of Pathology, 175, 489\u2013499.","journal-title":"American Journal of Pathology"},{"key":"10259_CR14","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1158\/0008-5472.CAN-07-5046","volume":"68","author":"KD Cowden Dahl","year":"2008","unstructured":"Cowden Dahl, K. D., Symowicz, J., Ning, Y., Gutierrez, E., Fishman, D. A., Adley, B. P., et al. (2008). Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Research, 68, 4606\u20134613.","journal-title":"Cancer Research"},{"key":"10259_CR15","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1124\/mol.105.021048","volume":"69","author":"JH Kim","year":"2006","unstructured":"Kim, J. H., Jeong, J. H., Jeon, S. T., Kim, H., Ock, J., Suk, K., et al. (2006). Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages. Molecular Pharmacology, 69, 1783\u20131790.","journal-title":"Molecular Pharmacology"},{"key":"10259_CR16","doi-asserted-by":"publisher","first-page":"27555","DOI":"10.18632\/oncotarget.4515","volume":"6","author":"J Luo","year":"2015","unstructured":"Luo, J., Lee, S. O., Cui, Y., Yang, R., Li, L., & Chang, C. (2015). Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5\/HIF2alpha\/androgen receptor signals. Oncotarget, 6, 27555\u201327565.","journal-title":"Oncotarget"},{"key":"10259_CR17","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","volume":"3","author":"S Deng","year":"2022","unstructured":"Deng, S., Wang, C., Wang, Y., et al. (2022). Ectopic JAK\u2013STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nature Cancer, 3, 1071\u20131087. https:\/\/doi.org\/10.1038\/s43018-022-00431-9","journal-title":"Nature Cancer"},{"issue":"3","key":"10259_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh, N., Baby, D., Rajguru, J. P., Patil, P. B., Thakkannavar, S. S., & Pujari, V. B. (2019). Inflammation and cancer. Annals of African Medicine, 18(3), 121\u2013126. https:\/\/doi.org\/10.4103\/aam.aam_56_18","journal-title":"Annals of African Medicine"},{"issue":"Suppl 1","key":"10259_CR19","doi-asserted-by":"publisher","first-page":"i104","DOI":"10.1136\/ard.2010.140145","volume":"70","author":"SI Grivennikov","year":"2011","unstructured":"Grivennikov, S. I., & Karin, M. (2011). Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage. Annals of the Rheumatic Diseases, 70(Suppl 1), i104\u2013i108. https:\/\/doi.org\/10.1136\/ard.2010.140145","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10259_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2008.12.011","volume":"282","author":"L Khandrika","year":"2009","unstructured":"Khandrika, L., Kumar, B., Koul, S., Maroni, P., & Koul, H. K. (2009). Oxidative stress in prostate cancer. Cancer Letters, 282(2), 125\u2013136. https:\/\/doi.org\/10.1016\/j.canlet.2008.12.011","journal-title":"Cancer Letters"},{"issue":"1","key":"10259_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1158\/1541-7786.MCR-19-0595","volume":"18","author":"JP Maynard","year":"2020","unstructured":"Maynard, J. P., Ertunc, O., Kulac, I., Baena-Del Valle, J. A., De Marzo, A. M., & Sfanos, K. S. (2020). IL8 expression is associated with prostate cancer aggressiveness and androgen receptor loss in primary and metastatic prostate cancer. Molecular Cancer Research, 18(1), 153\u2013165. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0595","journal-title":"Molecular Cancer Research"},{"issue":"7","key":"10259_CR22","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1074\/jbc.M109.048397","volume":"285","author":"Y Liang","year":"2010","unstructured":"Liang, Y., Zhong, Z., Huang, Y., Deng, W., Cao, J., Tsao, G., Liu, Q., Pei, D., Kang, T., & Zeng, Y. X. (2010). Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. The Journal of Biological Chemistry, 285(7), 4931\u20134940.","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10259_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12015-012-9364-9","volume":"8","author":"R Carrero","year":"2012","unstructured":"Carrero, R., Cerrada, I., Lled\u00f3, E., Dopazo, J., Garc\u00eda-Garc\u00eda, F., Rubio, M. P., Trigueros, C., Dorronsoro, A., Ruiz-Sauri, A., Montero, J. A., & Sep\u00falveda, P. (2012). IL1\u03b2 induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-\u03baB. Stem Cell Reviews and Reports, 8(3), 905\u2013916. https:\/\/doi.org\/10.1007\/s12015-012-9364-9","journal-title":"Stem Cell Reviews and Reports"},{"issue":"10","key":"10259_CR24","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/stem.2859","volume":"36","author":"S Skvortsov","year":"2018","unstructured":"Skvortsov, S., Skvortsova, I. I., Tang, D. G., & Dubrovska, A. (2018). Concise review: Prostate cancer stem cells: Current understanding. Stem Cells, 36(10), 1457\u20131474. https:\/\/doi.org\/10.1002\/stem.2859","journal-title":"Stem Cells"},{"key":"10259_CR25","doi-asserted-by":"publisher","first-page":"1269624","DOI":"10.1155\/2020\/1269624","volume":"2020","author":"C Han","year":"2020","unstructured":"Han, C., Wang, Z., Xu, Y., Chen, S., Han, Y., Li, L., Wang, M., & Jin, X. (2020). Roles of reactive oxygen species in biological behaviors of prostate cancer. BioMed Research International, 2020, 1269624. https:\/\/doi.org\/10.1155\/2020\/1269624","journal-title":"BioMed Research International"},{"issue":"1","key":"10259_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.stem.2014.04.002","volume":"15","author":"Y Lu","year":"2014","unstructured":"Lu, Y., Loh, Y. H., Li, H., Cesana, M., Ficarro, S. B., Parikh, J. R., Salomonis, N., Toh, C. X., Andreadis, S. T., Luckey, C. J., Collins, J. J., Daley, G. Q., & Marto, J. A. (2014). Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. Cell Stem Cell., 15(1), 92\u2013101. https:\/\/doi.org\/10.1016\/j.stem.2014.04.002","journal-title":"Cell Stem Cell."},{"issue":"7","key":"10259_CR27","doi-asserted-by":"publisher","first-page":"44125","DOI":"10.1038\/srep44125.PMID:28281569;PMCID:PMC5345072","volume":"10","author":"B Bao","year":"2017","unstructured":"Bao, B., Mitrea, C., Wijesinghe, P., Marchetti, L., Girsch, E., Farr, R. L., Boerner, J. L., Mohammad, R., Dyson, G., Terlecky, S. R., & Bollig-Fischer, A. (2017). Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity. Science and Reports, 10(7), 44125. https:\/\/doi.org\/10.1038\/srep44125.PMID:28281569;PMCID:PMC5345072","journal-title":"Science and Reports"},{"issue":"7","key":"10259_CR28","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/1878-0261.12316","volume":"12","author":"EA Teslow","year":"2018","unstructured":"Teslow, E. A., Bao, B., Dyson, G., Legendre, C., Mitrea, C., Sakr, W., Carpten, J. D., Powell, I., & Bollig-Fischer, A. (2018). Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type. African American PCa cells. Molecular oncology, 12(7), 1138\u20131152. https:\/\/doi.org\/10.1002\/1878-0261.12316","journal-title":"African American PCa cells. Molecular oncology"},{"key":"10259_CR29","doi-asserted-by":"publisher","unstructured":"Bao B, Teslow EA, Mitrea C, Boerner JL, Dyson G, Bollig-Fischer A. Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer. Mol Cancer Res. 2020 Dec;18(12):1803\u20131814. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0359","DOI":"10.1158\/1541-7786.MCR-20-0359"},{"issue":"1","key":"10259_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12935-023-02942-6.PMID:37231419;PMCID:PMC10210312","volume":"23","author":"SA Ayodeji","year":"2023","unstructured":"Ayodeji, S. A., Bao, B., Teslow, E. A., Polin, L. A., Dyson, G., Bollig-Fischer, A., & Fehl, C. (2023). Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer. Cancer Cell International, 23(1), 102. https:\/\/doi.org\/10.1186\/s12935-023-02942-6.PMID:37231419;PMCID:PMC10210312","journal-title":"Cancer Cell International"},{"key":"10259_CR31","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.2147\/OTT.S161760","volume":"11","author":"F Jin","year":"2018","unstructured":"Jin, F., Miao, Y., Xu, P., & Qiu, X. (2018). IL-8 regulates the stemness properties of cancer stem cells in the small-cell lung cancer cell line H446. OncoTargets and Therapy, 11, 5723\u20135731. https:\/\/doi.org\/10.2147\/OTT.S161760","journal-title":"OncoTargets and Therapy"},{"issue":"2","key":"10259_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3892\/or.2020.7631","volume":"44","author":"X Zhao","year":"2020","unstructured":"Zhao, X., Ma, L., Dai, L., Zuo, D., Li, X., Zhu, H., & Xu, F. (2020). TNF \u03b1 promotes the malignant transformation of intestinal stem cells through the NF \u03baB and Wnt\/\u03b2 catenin signaling pathways. Oncology Reports, 44(2), 577\u2013588. https:\/\/doi.org\/10.3892\/or.2020.7631","journal-title":"Oncology Reports"},{"issue":"8","key":"10259_CR33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","volume":"8","author":"A Mehta","year":"2018","unstructured":"Mehta, A., Kim, Y. J., Robert, L., Tsoi, J., Comin-Anduix, B., Berent-Maoz, B., Cochran, A. J., Economou, J. S., Tumeh, P. C., Puig-Saus, C., & Ribas, A. (2018). Immunotherapy resistance by inflammation-induced dedifferentiation. Cancer Discov., 8(8), 935\u2013943. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1178","journal-title":"Cancer Discov."},{"key":"10259_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature11538","volume":"490","author":"J Landsberg","year":"2012","unstructured":"Landsberg, J., Kohlmeyer, J., Renn, M., et al. (2012). Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature, 490, 412\u2013416. https:\/\/doi.org\/10.1038\/nature11538","journal-title":"Nature"},{"key":"10259_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41419-017-0027-2","volume":"9","author":"S Missiroli","year":"2018","unstructured":"Missiroli, S., Patergnani, S., Caroccia, N., et al. (2018). Mitochondria-associated membranes (MAMs) and inflammation. Cell Death & Disease, 9, 329. https:\/\/doi.org\/10.1038\/s41419-017-0027-2","journal-title":"Cell Death & Disease"},{"key":"10259_CR36","doi-asserted-by":"crossref","unstructured":"Powell IJ, Bock CH, Ruterbusch JJ, Sakr W. Evidence supports a faster growth rate and\/or earlier transformation to clinically significant prostate cancer in black than in white American men and influences racial progression and mortality disparity. The Journal of Urology. 05\/01\/2010;183(5):1792\u20136","DOI":"10.1016\/j.juro.2010.01.015"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-025-10259-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-025-10259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T09:19:17Z","timestamp":1751015957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-025-10259-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["10259"],"URL":"https:\/\/doi.org\/10.1007\/s10555-025-10259-1","relation":{},"ISSN":["1573-7233"],"issn-type":[{"type":"electronic","value":"1573-7233"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}